Malte from Portugal

Registered at the short selling broker eToro, 5 minutes ago.

» Try eToro you too
75% of retail investor accounts lose money when trading CFDs with etoro.
Don't show again

Intercept Pharmaceuticals, Inc (ICPT) shares information

Intercept Pharmaceuticals, Inc.


24h Change

2.69 %

ICPT

Live rate: Market closed

Stock data per Wednesday 25 Nov, 2020

ICPT
NASDAQ
36.41
36.36
37.39
0.98 (+ 2.69%)
US Market is closed

Live Stock price in graph for Intercept Pharmaceuticals, Inc. (ICPT)

  • Latest Volume

    596,672 (4.93 %)

  • Volume prev. day

    568,632

  • Avg. daily volume

    874,849

  • Market cap

    1,233,585,836

  • P/E ratio

    -3.82

  • Today high

    38.08 USD

  • Today low

    36.22 USD

  • 52 week high

    125 USD

  • 52 week low

    27.02 USD

  • YTD Change

    n/a

Quick links

Broker recommendations for Intercept Pharmaceuticals, Inc

The Intercept Pharmaceuticals, Inc stock is rated at 1.695652 (on a scale 1-3, where 1 is ‘strong buy‘ and 3 is ‘strong sell‘) from Wednesday 18 November, 2020 by a total of 23 brokers. This means that the consensus of the 23 different brokers is leaning toward to moderate buy/hold.

Sell
0 (0%)
Underweight
0 (0%)
Hold
15 (65.22%)
Overweight
2 (8.7%)
Buy
6 (26.09%)

Price target by analysts

The 23 latest analyst estimates, per Friday 27 November, 2020, show the following high, low and average price targets.
Target Average: 56.39 USD
Target High: 116 USD
Target Low: 33 USD

 

Latest news about Intercept Pharmaceuticals, Inc.

Below you can find the most recent news posts about Intercept Pharmaceuticals, Inc., primarily from US and UK based news sources.

ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Intercept Pharmaceuticals, Inc. Investors of Important January 4 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm – ICPT – Stocks News Feed

Thursday, 26 November 2020, 18:44:00
NEW YORK, Nov. 26, 2020 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) between September 28, 2019 and October 7, 2020, inclusive (the “Class Period”), of the important January 4, 2021 lead plaintiff deadline in the securities class action. The… Read More »ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Intercept Pharmaceuticals, Inc. Investors of Important January 4 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm – ICPT
— Stocks News Feed


ROSEN, A LEADING LAW FIRM, Reminds Intercept Pharmaceuticals, Inc. Investors of Important January 4 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm – ICPT

Wednesday, 25 November 2020, 01:28:00
NEW YORK, Nov. 24, 2020 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) between September 28, 2019 and October 7, 2020, inclusive (the “Class Period”), of the important January 4,…
— PR Newswire


ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Reminds Intercept Pharmaceuticals, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm – ICPT

Friday, 20 November 2020, 22:42:00
NEW YORK–(BUSINESS WIRE)–Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) between September 28, 2019 and October 7, 2020, inclusive (the “Class Period”), of the important January 4, 2021 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Intercept investors under the federal securities laws. To join the Intercept class action, go to http://www.rosenlegal.com/c
— Business Wire


Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Intercept Pharmaceuticals, Neovasc, Interface, and Biogen and Encourages Investors to Contact the Firm – Stocks News Feed

Thursday, 19 November 2020, 03:00:00
NEW YORK, Nov. 18, 2020 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT), Neovasc, Inc. (NASDAQ:NVCN), Interface, Inc. (NASDAQ:TILE), and Biogen, Inc. (NASDAQ:BIIB). Stockholders have until the deadlines below to petition… Read More »Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Intercept Pharmaceuticals, Neovasc, Interface, and Biogen and Encourages Investors to Contact the Firm
— Stocks News Feed


ICPT Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Intercept Pharmaceuticals, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: January 4, 2021

Tuesday, 17 November 2020, 17:00:00
NEW YORK–(BUSINESS WIRE)–Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Intercept Pharmaceuticals, Inc. (“Intercept” or “the Company”) (NASDAQ: ICPT) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Intercept securities between September 28, 2019 and October 7, 2020, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.b
— Business Wire


Trading broker recommendation

We recommend that you check out Capital.com as they have a very good selection of stocks available for both going short and long.

Rating: 9.57/10
Minimum deposit: €200
Description: Capital.com offer a large number of stocks for trading. Register an account today and check if they have ICPT available or trade one of the many other CFD stocks they have.
Risk warning: 75% of retail investor accounts lose money when trading CFDs with Capital.